The policy of public health genomics in Italy

Abstract Italy has a monitoring system for genetic testing, consisting in a periodic census of clinical and laboratory activities performed in the country. The experience is limited, however, concerning the translation of genomic testing for complex diseases into clinical practice. For the first tim...

Full description

Saved in:
Bibliographic Details
Published in:Health policy (Amsterdam) 2013-05, Vol.110 (2), p.214-219
Main Authors: Simone, Benedetto, Mazzucco, Walter, Gualano, Maria Rosaria, Agodi, Antonella, Coviello, Domenico, Dagna Bricarelli, Francesca, Dallapiccola, Bruno, Di Maria, Emilio, Federici, Antonio, Genuardi, Maurizio, Varesco, Liliana, Ricciardi, Walter, Boccia, Stefania
Format: Article
Language:English
Subjects:
Biological and medical sciences
Census
Censuses
Delivery of Health Care - legislation & jurisprudence
Diseases
Economic conditions
First time
Genetic Diseases, Inborn - genetics
Genetic Diseases, Inborn - prevention & control
Genetic testing
Genetic Testing - legislation & jurisprudence
Genomics - legislation & jurisprudence
Government policy
Health administration
Health care
Health Planning
Health Policy
Humans
Income
Internal Medicine
Italy
Laboratories
Medical sciences
Medical service
Medicine
Miscellaneous
Policy
Prevention
Public health
Public Health - legislation & jurisprudence
Public health genomics
Public health. Hygiene
Public health. Hygiene-occupational medicine
Testing
Translation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Italy has a monitoring system for genetic testing, consisting in a periodic census of clinical and laboratory activities performed in the country. The experience is limited, however, concerning the translation of genomic testing for complex diseases into clinical practice. For the first time the Italian Ministry of Health has introduced a policy strategic plan on genomics and predictive medicine within the 2010–2012 National Prevention Plan. This achievement was supported by the Italian Network for Public Health Genomics (GENISAP) and will likely contribute to the integration of public health genomics into health care in the country. Our experience might be of interest not only in Italy, but in other high-income countries, struggling to keep a healthy economy and healthy citizens.
ISSN:0168-8510
1872-6054
DOI:10.1016/j.healthpol.2013.01.015